Danielle Nicolazzo, DO was born in Boston, MA. She attended the University of Michigan where she received a bachelor in Biopsychology. She then attended Boston University where she obtained a post-baccalaureate in medical sciences. She went to medical school at Nova-Southeastern University and completed a Traditional Rotating Internship at Larkin Community Hospital. She is currently a third year dermatology resident at Larkin Community Hospital and plans to remain working in South Florida after she graduates.
Medical Dermatology Update
This lecture will introduce basic approaches to complex medical dermatology with specific diseases being reviewed.
- How to manage and identify complex medical dermatology cases
- Learn various presentations and variations of skin conditions
- New treatments on the horizon
- Review histopathology of unique and difficult cases
- Explore different treatment options for difficult to manage cases
- Diagnosis and pathophysiology of select diseases
- New advances in dermatologic treatment
- Availability of new medication(s) and indication(s)
- Advances in medical knowledge
- New methods of diagnosis or treatment
- Development of new technology
- Legislative, regulatory, or organizational changes effecting patient care
- Bolognia, Jean L., et al. “Dermatology” Section 4, Chapter 20, pg 323-332. Mosby Elsevier. 2008.
- Chong, Huey Ti, et al. “Cost-Effectiveness analysis of HLA-B*58”. Pharmacogenetics and Genomics, 2017, p. 1, doi:10.1097/fpc.0000000000000319.
- Bolognia 2nd edition, North, Paula E, Kincannon, Jay. Section 18, Chapter 114, pg. 1788.
- Weedon’s Skin Pathology, Weedon, David. Section 7, Chapter 38, pg. 920.
- Bolognia 2nd Edition – Section 7/42, pg. 583.
- Carter, A., Orgega-Loayza, AG., Barrett, J., Nunley, J., “Calciphylaxis with evidence of hypercoagulability successfully treated with unfractionated heparin: a multidisciplinary approach”. Clinical and Experimental Dermatology. Doi:10.1111/ced.12729.
- Speeckaert MM, Devreese KMJ, Vanholder RC, Dhondt A. “Fondaparinux as an alternative to vitamin K antagonists in haemodialysis patients”. Nephrology Dialysis Transplantation. 2013;28(12):3090-3095. Doi:10.1093/ndt/gft293.
Core Competencies: 1, 2, 3, 4, 6, 7
Disclosures: No disclosures provided by speaker